Última Hora: "Isabel dos Santos perde apoio do Estado angolano na Efacec - PÚBLICO" Fri, 17 Aug 2018 10:49:35 GMT    "Tesla enredada no folhetim saudita. ?Deixa de tuitar, Elon? - Expresso" Sat, 18 Aug 2018 11:00:52 GMT    "BE quer desigualdade salarial sujeita a multas - Correio da Manhã" Sat, 18 Aug 2018 08:54:35 GMT   "" Sat, 18 Aug 2018 12:42:12 GMT    "Conheça o eléctrico em forma de ovo que faz 120 quilómetros por 1,50 euros - DNoticias" Sat, 18 Aug 2018 12:00:05 GMT    "Governo aprova investimento de 81 milhões de euros em três centrais solares em Santarém - Observador" Sat, 18 Aug 2018 10:46:00 GMT    "Descentralização: Governo recua e dá mais tempo às câmaras - Jornal de Negócios - Portugal" Fri, 17 Aug 2018 15:41:36 GMT    "Câmara de Silves com novas viaturas pesadas - Região Sul" Sat, 18 Aug 2018 07:37:00 GMT    "Grécia e zona euro celebram na segunda-feira fim de oito anos de resgates - Observador" Sat, 18 Aug 2018 10:57:00 GMT    "Barragem de mais de 10 milhões promete mudar o cultivo da terra em Vila Flor - Jornal de Negócios - Portugal" Sat, 18 Aug 2018 09:48:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Sem variação
Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última Trade0,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade - 00:00:00Price-Target 1 Ano0,000
VariaçãoN/A (N/A)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura0,000PER0,00%
Máximo0,000Pagamento Dividendo
Mínimo0,000Data Ex-Dividendo
Fecho Anterior0,000Yield
Volume0Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Tactical Business

Global Asthma Medication Market Demand 2018- AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc ...
Tactical Business
Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The report also takes into account the latest enhancements while foretelling the expansion of the key players.


New Mexico Courier Express

Global Desloratadine Industry 2018 ? Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor ...
New Mexico Courier Express
... Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan Poly Pharm ...

e mais »

Fair Reporter

Allergy Treatment Market: Key strategies of major players by 2016?2024
Fair Reporter
... market are Allergopharma, Allergy Therapeutics, Alerpharma S.A, Allergon AB, Genentech Inc., Allergan, Inc., McNeil Consumer Healthcare, Schering-Plough Corporation, Meda Pharmaceuticals, Inc, Collegium Pharmaceutical, Inc., Vicks, and Sepracor, ...

e mais »

Global Loratadine Market 2018 Outline- Mylan, Sepracor, Sandoz
faircolumnist.com
This latest research report that completely centers Global Loratadine Market is an intensive analysis of propulsive forces, propulsive risks, business opportunities, Loratadine threats and challenges includes in Loratadine market. It provides ...

e mais »

364Analyze.com (press release)

Market Research on Allergy Treatment Market 2016 and Analysis to 2026
364Analyze.com (press release)
... market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and ...

e mais »

BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO
BSA bureau (press release)
In 2010, Sunovion (formerly Sepracor Inc.), was acquired by Sumitomo Dainippon. Nomura took the position of the Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc. in 2012. Following 2014, he became associated with the ...

e mais »

Desloratadine Market Report 2018 Global: Top Manufacturers Revenue, Type And Applications Prediction To 2025
theaerospacenews.com
Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...

e mais »

Stock Analysis

Global Desloratadine Market Report Segmentation, Consumption, Present Situation, Competitors and Forecast by 2025
Stock Analysis
A market study based on the Desloratadine Market across the globe, recently added to the repository of Market Research, is titled 'Global Desloratadine Market 2018'. The research report analyses the historical as well as present performance of the ...

e mais »

Desloratadine Market Growth Opportunities, Industry Analysis, Share, Geographic Segmentation and Competitive ...
theperfectinvestor.com
Desloratadine Market Report Delivers an in depth approximation of the succeeding technology, Key plans, Challenges, Market drivers, Standardization, organizational scene, distributing fashions, overtures, upcoming guide, admiration chain.

e mais »

Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
GlobeNewswire (press release)
Mr. Hastings also previously served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. During his tenure at ArQule, he played an important role in ArQule's transition into a drug discovery and development organization, and in two ...


Business Wire (press release)

Rodin Therapeutics Expands Leadership Team, Adding Extensive Experience in Clinical and Business Development
Business Wire (press release)
She then joined Sunovion Pharmaceuticals, Inc. (formerly Sepracor), moving through positions of increasing responsibility into the role of vice president for corporate development and licensing. Sullivan played an instrumental role in the company's ...


Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Prior to Auxilium, he was Vice President, General Counsel and Corporate Secretary of Enobia Pharma, Inc. Prior to that, Mr. Trachtenberg served as Vice President and Associate General Counsel of Sepracor Inc. (now known as Sunovion Pharmaceuticals ...

e mais »

Desloratadine Market Outlook 2018 Global: Top Companies, Trends And Progress Factors Specifics For Business ...
Newszak (blog)
Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...

e mais »

Business Wire (press release)

BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, MD, as ...
Business Wire (press release)
Dr. Currie has over 25 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. and PDL Biopharma.

e mais »

Desloratadine Market Analysis by Product Types, Marketing Channel Development Trend, Market Effect Factors ...
trueindustrynews.com
Pfizer; Teva; Wante Pharmaceutical; Novartis India Limited; Mylan; Sepracor; Sandoz; Apollo Pharmaceuticals; GSK; Mayne Pharma Inc; Abhilasha Pharma Pvt; Abbott; Takeda; Schering-Plough; Nanjing Hicin Pharmaceutical; Hairui Pharmaceutical; Hainan ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters